Funded Tech Companies
Cleave Therapeutics
Headquartered in San Francisco, Cleave Therapeutics is venture-backed, with investment from Celgene, Astellas Venture Capital and OrbiMed.
Company Overview
Company Name
Cleave Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
135 Main St. 1145
San Francisco, CA 94105
USA
San Francisco, CA 94105
USA
Phone
Website
Email Address
Company Background Information
Overview
Cleave Therapeutics is a biopharmaceutical company focused on valosin-containing protein (VCP)/p97 as a novel target in protein homeostasis and cellular stress pathways for therapeutic use in cancer and neurodegenerative diseases. There is a growing body of evidence around inhibiting VCP to target cancer stress pathways with known biological relevance in cancer.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
8/8/2019
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Amy Burroughs
Chief Operating Officer
Scott Harris
Company Investors
- Celgene
- Astellas Venture Capital
- OrbiMed (Peter Thompson)
- U.S. Venture Partners
- Arcus Ventures
- Osage Partners
- 5AM Ventures
Browse more funded tech companies:
Share this article
About Our VC Deals Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs